Attached files
| file | filename |
|---|---|
| EX-32 - CERTIFICATION - INOLIFE TECHNOLOGIES, INC. | inol_ex32.htm |
| EX-31.2 - CERTIFICATION - INOLIFE TECHNOLOGIES, INC. | inol_ex312.htm |
| EX-31.1 - CERTIFICATION - INOLIFE TECHNOLOGIES, INC. | inol_ex311.htm |
| EX-13 - ANNUAL REPORT - INOLIFE TECHNOLOGIES, INC. | inol_ex13.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 29, 2016
INOLIFE TECHNOLOGIES INC |
(Exact Name of Registrant as Specified in Charter) |
New York
(State or Other Jurisdiction of Incorporation)
000-50863
(Commission File Number)
30-299889
(I.R.S. Employer Identification No.)
300 Spectrum Center Drive, Suite 400, Irvine CA 92618
(Address of Principal Executive Offices)
(866) 834-3777
(Issuer Telephone Number)
Copies to:
Randall Lanham, Esq.
Lanham & Lanham, LLC
28562 Oso Parkway, Unit D
Rancho Santa Margarita, CA 92688
(949) 933-1964 Tel
(949) 666-5006 Fax
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 DFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d- 2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4 (c) under the Exchange Act (17 CFR 240.13e- 4(c))
InoLife Technologies, Inc.
CURRENT REPORT ON FORM 8-K
TABLE OF CONTENTS
Item 9.01 Financial Statements and Exhibits
| 2 |
Section 9. Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
| 13 | Annual report to security holders, Form 10-Q and 10-QSB, or quarterly report to security holders |
| 31.1 | Certification |
| 31.2 | Certification |
| 32 | Certification |
| 3 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to besigned on its behalf by the undersigned thereunto duly authorized.
| InoLife Technologies, Inc. | |||
| Date: July 29, 2016 | By: | /s/ Dr. John Oda | |
|
| Dr.John Oda | |
Chief Executive Officer | |||
4 |